This episode of the OIS Podcast was a featured panel discussion with the following industry executives from the Dry Eye Innovation Showcase. 

Paul Karpecki, OD, FAAO, moderates the conversation with:
Doug Faunce, PhD, Allergan/AbbVie
Sajjad Roshanali, Johnson & Johnson Vision
Rob Kissling, MD, Bausch + Lomb
Mark Hagler, Sun Pharma
Jehan Tamboowalla, Novartis

The panelists shared candid insights on:

- The main driving forces and opportunities in this specialty.
- How their companies plan strategic moves, and what they look for to expand their current portfolio of dry eye therapies.
- Challenges they are encountering and strategies to overcome them.
- The value of developing point-of-care diagnostics.
- Initiatives to raise awareness of doctors and consumers. 

Click play to hear these valuable insights!

For this week’s episode of the OIS Podcast we are sharing the “Clinical Perspective” panel discussion from our recent Dry Eye Innovation Showcase. The following KOLs delivered some fascinating strategies on addressing this massively underserved patient population. 

Ashley Brissette, MD
Ana Alzaga Fernandez, MD
Cynthia Matossian, MD, FACS 
Laura Periman, MD
Yuna Rapoport, MD, MPH
Rahul S. Tonk, MD, MBA
Paul Karpecki, OD, FAAO

Discussion points include:

• The complexity of dry eye disease
• Identifying the root causes.
• Optimal treatments for varying conditions.
• The importance of educating patients.

Click play to get enlightened!
REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.

In this episode of the OIS Podcast, Tracy Valorie tells host Ehsan Sadri, MD, that one of the most important things in business relationships is building trust. She explains that you can’t always make everybody happy in a business situation, but if you come at it from a strong place of trust you can make something exciting happen.

Valorie knew in 7th grade that she wanted to explore science, and her interest led her into several roles at Pfizer Labs, and eventually to the position of senior VP and general manager of ophthalmology at Bausch + Lomb. She now serves as a consultant to small ophthalmology start-ups, with an eye toward leapfrog technologies. 

In addition to discussing her experiences with large companies and start-ups, Valorie outlines how she moved through her career and gives tips on how others can outline their own path, including not to be afraid of taking the next step. 

Click “play” to hear this fascinating talk!

Our newest host, Rob Rothman, MD is shaking things up to bring fresh voices and ideas to the OIS Podcast. 

In what turned out to be the most fascinating podcast discussion to date, we had the privilege to speak with Bruce Ksander, Associate Professor of Ophthalmology at Harvard Medical School, who has also contributed to the highly-acclaimed book, Lifespan. 

Bruce opened our eyes, dropped our jaws, and completely blew our minds with research being conducted on reprogramming damaged cells to reverse the aging process. Tune in now for this mind-expanding and thought-provoking discussion around the future of regenerative medicine and the impact on age-related eye disorders.

You don’t want to miss this conversation -press play to listen!

On this special episode of the OIS Podcast, we’re sharing the panel discussion from our recent Gene Therapy Innovation Showcase. We have Peter Francis MD, PhD from 4D Molecular Therapeutics; Jeffrey S. Heier, MD of Ophthalmic Consultants of Boston; Arshad Khanani, MD of Sierra Eye Associates; Jose-Alain Sahel, MD, of UPMC Eye Center; and Glenn Yiu, MD, PhD, from UC Davis Health. 

Our panelists assess the current landscape of gene therapy and addresses how the sector is evolving to go far beyond treating only inherited retinal diseases. They discuss promising clinical trials and how the future could transform to benefit many patients outside of retina thanks to new advancements.

Press play to listen in!

On this week’s episode of the OIS Podcast, Robert Rothman, MD, is joined by Vince Anido, Chairman and CEO of Aerie Pharmaceuticals. 

Vince shares his vision for Aerie, and how his lean, efficient team carefully strategizes every move they make to cultivate products that benefit patients. We learn background on both Vince and Aerie, and how two of Aerie’s products, Rhopressa and Rocklatane, were brought to market in under one year. How has Aerie has made a name for themselves globally within glaucoma, and next in dry eye, and retina?

On this week’s episode of the OIS Podcast, Firas Rahhal, MD, is joined by Calvin Roberts, MD, CEO of Lighthouse Guild. 

Cal has over 36 years under his belt in the eye care sector ranging from academia, private practice, and industry. He shares the positive and the negative of transitioning from a private practice on Park Ave over to being the Chief Medical Officer of Bausch + Lomb. Listen in for important factors to consider such as autonomy, security, and the impact on those around you when considering the leap over to industry. 

We’ll also learn how Cal is weaving his previous experiences into the work he is doing for Lighthouse Guild and how they strive to reduce the burdens of vision loss for patients.

This week on the OIS Podcast, Paul Karpecki, OD, FAAO, speaks with the new CEO of TearClear, Robert Dempsey, to uncover what has been necessary for him to succeed in the space. 

Listen in as Robert discusses the importance of assembling a trustworthy crew before zeroing in on goals and objectives. Learn how his professional experiences have helped him build out a unique Medical Advisory Board for TearClear comprised of 50% optometry and 50% ophthalmology and what the future of TearClear looks like. 

Press play now and learn from one of the best!

We have a great conversation for you this week on the OIS Podcast: Paul Karpecki, OD, FAAO, joins Kim Brazzell, PhD and Chief Medical Officer at Kala Pharmaceuticals, to discuss Kim’s experience developing EYSUVIS, the first FDA-approved prescription therapy specifically developed to address the short-term treatment needs of people living with dry eye disease.

Kim gives us tips for navigating the approval process and shares lessons learned since he started working in the space. You don’t want to miss this episode. Press play now!